Rogers, K. A., Andritsos, L. A., Wei, L., McLaughlin, E. M., Ruppert, A. S., Anghelina, M., . . . Grever, M. R. (2021). Phase 2 study of ibrutinib in classic and variant hairy cell leukemia. Blood.
Citação norma ChicagoRogers, Kerry A., et al. "Phase 2 Study of Ibrutinib in Classic and Variant Hairy Cell Leukemia." Blood 2021.
ציטוט MLARogers, Kerry A., et al. "Phase 2 Study of Ibrutinib in Classic and Variant Hairy Cell Leukemia." Blood 2021.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.